loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2004_060___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    API Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 API CORPORATION Chuo-ku JP (1)

    filter

    01 Methyl salicylate (1)

    filter

    01 Japan (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    API CORPORATION Chuo-ku JP

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl salicylate

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2004-060 - Rev 02
    Withdrawn by Holder
    Chemical
    2013-04-09
    2022-01-14
    230
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-060 - Rev 02 of Api Corporation Chuo-ku Jp

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-060 - Rev 02 of Api Corporation Chuo-ku Jp 1

    20

    Api Corporation Chuo-ku Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Methyl salicylate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-060 - Rev 02

    This Chemical Type CEP, issued on April 09, 2013, remains in force until January 14, 2022, ensuring its reliability within the pharmaceutical industry.

    Substance Number 230 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY